Financhill
Sell
38

CMPR Quote, Financials, Valuation and Earnings

Last price:
$71.93
Seasonality move :
-1.13%
Day range:
$71.63 - $74.21
52-week range:
$35.21 - $82.43
Dividend yield:
0%
P/E ratio:
80.32x
P/S ratio:
0.51x
P/B ratio:
--
Volume:
68.5K
Avg. volume:
136.9K
1-year change:
44.19%
Market cap:
$1.8B
Revenue:
$3.4B
EPS (TTM):
$0.90

Analysts' Opinion

  • Consensus Rating
    Cimpress Plc has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $97.50, Cimpress Plc has an estimated upside of 34.97% from its current price of $72.24.
  • Price Target Downside
    According to analysts, the lowest downside price target is $95.00 representing 100% downside risk from its current price of $72.24.

Fair Value

  • According to the consensus of 1 analyst, Cimpress Plc has 34.97% upside to fair value with a price target of $97.50 per share.

CMPR vs. S&P 500

  • Over the past 5 trading days, Cimpress Plc has underperformed the S&P 500 by -4.7% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cimpress Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cimpress Plc has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Cimpress Plc reported revenues of $1B.

Earnings Growth

  • Cimpress Plc earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cimpress Plc reported earnings per share of $1.95.
Enterprise value:
3.3B
EV / Invested capital:
2.65x
Price / LTM sales:
0.51x
EV / EBIT:
13.02x
EV / Revenue:
0.91x
PEG ratio (5yr expected):
0.12x
EV / Free cash flow:
21.54x
Price / Operating cash flow:
11.94x
Enterprise value / EBITDA:
8.27x
Gross Profit (TTM):
$1.7B
Return On Assets:
1%
Net Income Margin (TTM):
0.55%
Return On Equity:
--
Return On Invested Capital:
1.67%
Operating Margin:
8.58%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $3.2B $3.4B $3.6B $939.2M $1B
Gross Profit $1.5B $1.6B $1.7B $444.8M $484.8M
Operating Income $220M $226.4M $249.9M $81.1M $89.4M
EBITDA $379.6M $369.9M $393.5M $116.3M $126M
Diluted EPS $1.52 $6.03 $0.90 $2.36 $1.95
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $630.6M $525.3M $578M $495.6M $561.2M
Total Assets $2.3B $2B $1.9B $1.9B $2.1B
Current Liabilities $705.2M $696.7M $707.7M $727.8M $826.1M
Total Liabilities $2.6B $2.5B $2.5B $2.5B $2.6B
Total Equity -$298M -$589M -$528.6M -$535M -$524M
Total Debt $1.8B $1.8B $1.7B $1.7B $1.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $295.3M $311.5M $321.8M $173.9M $164.3M
Cash From Investing -$34.2M -$90.4M -$200.8M -$40.6M -$73.1M
Cash From Financing -$114.5M -$263.3M -$97.6M -$53.3M -$34.2M
Free Cash Flow $258M $187.1M $151.1M $131.9M $123.2M
CMPR
Sector
Market Cap
$1.8B
$477M
Price % of 52-Week High
87.64%
84.06%
Dividend Yield
0%
0%
Shareholder Yield
3.01%
1.68%
1-Year Price Total Return
44.19%
--
Beta (5-Year)
1.752
0.541
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $74.13
200-day SMA
Buy
Level $60.96
Bollinger Bands (100)
Buy
Level 64.98 - 75.84
Chaikin Money Flow
Sell
Level -225.6K
20-day SMA
Sell
Level $76.12
Relative Strength Index (RSI14)
Sell
Level 41.80
ADX Line
Sell
Level 26.62
Williams %R
Buy
Level -90.0981
50-day SMA
Sell
Level $74.51
MACD (12, 26)
Buy
Level 16.08
25-day Aroon Oscillator
Buy
Level 8
On Balance Volume
Neutral
Level 29.6K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4021)
Sell
CA Score (Annual)
Level (-2.8746)
Buy
Beneish M-Score (Annual)
Level (-3.0944)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (11.8793)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cimpress Plc engages in web-to-print mass customization, delivering high-quality, affordable custom products quickly and conveniently even in low quantities. It operates through the following segments: Vista, PrintBrothers, Print Group, National Pen and All Other Businesses. The Vista segment consists of the operations of VistaPrint branded websites in North America, Western Europe, Australia, New Zealand, India, and Singapore. The PrintBrothers segment includes the results of druck.at, printdeal, and WIRmachenDRUCK businesses. The Print Group segment focuses on the results of Easyflyer, Exaprint, Pixartprinting, and Tradeprint businesses. The National Pen segment encompasses the global operations of nation pen business, which manufactures and markets custom writing instruments and promotional products, apparel and gifts. The All Other Buisnesses comprises of the collection of businesses grouped together based on materiality. The company was founded by Robert S. Keane in 1995 and is headquartered in Dundalk, Ireland.

Stock Forecast FAQ

In the current month, CMPR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CMPR average analyst price target in the past 3 months is $97.50.

  • Where Will Cimpress Plc Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cimpress Plc share price will rise to $97.50 per share over the next 12 months.

  • What Do Analysts Say About Cimpress Plc?

    Analysts are divided on their view about Cimpress Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cimpress Plc is a Sell and believe this share price will drop from its current level to $95.00.

  • What Is Cimpress Plc's Price Target?

    The price target for Cimpress Plc over the next 1-year time period is forecast to be $97.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CMPR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cimpress Plc is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of CMPR?

    You can purchase shares of Cimpress Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cimpress Plc shares.

  • What Is The Cimpress Plc Share Price Today?

    Cimpress Plc was last trading at $71.93 per share. This represents the most recent stock quote for Cimpress Plc. Yesterday, Cimpress Plc closed at $72.24 per share.

  • How To Buy Cimpress Plc Stock Online?

    In order to purchase Cimpress Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock